がんの生き残り戦略を逆手に取って治療する革新的マクロファージ医薬の普遍化

• Project/Area Number: 25K21828
• Research Category: Grant-in-Aid for Challenging Research (Pioneering)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 90:Biomedical engineering and related fields
• Research Institution: Kyushu University
• Principal Investigator: 新居 輝樹 九州大学, 工学研究院, 助教 (90908419)
• Project Period (FY): 2025-06-27 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥26,000,000 (Direct Cost: ¥20,000,000、Indirect Cost: ¥6,000,000); Fiscal Year 2027: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000); Fiscal Year 2026: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000); Fiscal Year 2025: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)